Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.60 |
| ▸ | F2 | P00734 | 4/20 | 0.59 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.57 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.57 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.57 |
| ▸ | NPY2R | P49146 | 3/20 | 0.57 |
| ▸ | NPY4R | P50391 | 3/20 | 0.57 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.57 |
| ▸ | NPY1R | P25929 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31688332 | 0.92 | OPRM1 (0.61) | CALCRF2OPRD1OPRM1OPRK1 | |
| SCHEMBL29867671 | 0.91 | F2 (0.62) | CALCRF2NPY2RNPY4RNPY5R | |
| SCHEMBL31182783 | 0.91 | CALCR (0.63) | CALCRF2NPY2RNPY4RNPY5R | |
| SCHEMBL31182439 | 0.91 | CALCR (0.63) | CALCRF2OPRD1OPRM1OPRK1 | |
| SCHEMBL31603945 | 0.90 | CALCR (0.64) | CALCRF2CRHR1CRHR2NPY2R | |
| SCHEMBL31683251 | 0.90 | OPRD1 (0.60) | CALCROPRD1OPRM1OPRK1 | |
| SCHEMBL30262116 | 0.90 | F2 (0.62) | CALCRF2OPRD1NPY2RNPY4R | |
| SCHEMBL30512573 | 0.90 | OPRD1 (0.57) | CALCRF2OPRD1CRHR1CRHR2 | |
| SCHEMBL31182911 | 0.89 | CALCR (0.65) | CALCRF2OPRD1OPRM1OPRK1 | |
| SCHEMBL30432005 | 0.89 | CALCR (0.62) | CALCRF2CRHR1CRHR2NPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250283037-A1 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | JUNO THERAPEUTICS GMBH (DE) | 2025-09-11 | — | — | US | disclosed |